News Releases

Sep 07, 2021
Axcella Announces Upcoming Investor Conference Presentation
Aug 16, 2021
Axcella Announces Publication in The American Journal of Gastroenterology of Positive Results from AXA1125-003 in Subjects With Presumed NASH
Jul 29, 2021
Axcella Reports Second Quarter Financial Results and Provides Business Update
Jul 22, 2021
Axcella to Report Second Quarter 2021 Financial Results on July 29, 2021
Jun 30, 2021
Axcella Announces Initiation of EMMPOWER℠ Phase 2 Clinical Trial of AXA1665
May 24, 2021
Positive Clinical Data About Axcella’s AXA1665 Candidate for Overt Hepatic Encephalopathy Highlighted in Oral Presentation at DDW 2021
May 11, 2021
Axcella Announces Initiation of EMMPACT℠ Phase 2b Clinical Trial of AXA1125
May 06, 2021
Axcella Reports First Quarter Financial Results and Provides Business Update
Apr 27, 2021
Axcella to Report First Quarter 2021 Financial Results on May 6, 2021
Apr 22, 2021
Axcella Announces Upcoming Oral Presentation at Digestive Disease Week (DDW) 2021
Displaying 1 - 10 of 18